Fluticasone Propionate Aerosol, Metered
Product Images NDC 50090-6055

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 50090-6055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)

Chemical structure of fluticasone propionate showing its molecular arrangement with various functional groups including hydroxyl, fluorine, and thioester groups. The diagram illustrates the steroid backbone as part of the compound's detailed chemical formula.*

FDA Label Image

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)

A line graph showing the percentage change from baseline in FEV1 over 12 weeks and at endpoint, comparing placebo and Fluticasone Propionate HFA 88 mcg twice daily. The Fluticasone group shows a higher increase in FEV1 percentage than the placebo group throughout the study period.*

FDA Label Image

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)

A line graph depicting the percent change from baseline in FEV1 over a 12-week period for four groups: placebo, Fluticasone Propionate HFA 88 mcg twice daily, 220 mcg twice daily, and 440 mcg twice daily. The x-axis represents weeks, and the y-axis shows percent change in FEV1 from baseline. Data points display differing trends for each treatment group throughout the study duration.*

FDA Label Image

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)

A bar chart comparing the percentage of subjects experiencing 100% reduction in dose and percentage of subjects with an increase in dose for placebo, Fluticasone Propionate HFA 440 mcg twice daily, and Fluticasone Propionate HFA 880 mcg twice daily groups. The chart shows higher reduction percentages in both Fluticasone Propionate HFA groups compared to placebo, with percentages labeled on each bar.*

FDA Label Image

Figure A (Fluticasonepropionatehfa Spl Graphic 05)

An illustration showing parts of a fluticasone propionate metered dose inhaler, including a metal canister, dark orange plastic actuator, dark orange mouthpiece, a counter, and a separate peach-colored protective cap.*

FDA Label Image

Figure B (Fluticasonepropionatehfa Spl Graphic 06)

An instructional illustration showing how to remove the cap from a metered-dose inhaler. The image depicts one hand holding the inhaler and the other hand pulling off the cap indicated by an arrow pointing away from the inhaler mouthpiece.*

FDA Label Image

Figure C (Fluticasonepropionatehfa Spl Graphic 07)

Instructional illustration showing a person using a Fluticasone Propionate HFA aerosol inhaler. The image demonstrates pressing down on the inhaler to release a spray, with an arrow indicating the direction of actuation towards the mouth for respiratory inhalation.*

FDA Label Image

Figure D (Fluticasonepropionatehfa Spl Graphic 08)

An instructional line drawing illustrating how to hold and use a metered-dose inhaler with a dose counter displaying '120'. The image shows a hand gripping the inhaler upright with the thumb at the base and the index finger on top, ready to press down.*

FDA Label Image

Figure E (Fluticasonepropionatehfa Spl Graphic 09)

Instructional illustration showing the 'Mouthpiece-Down position' for an inhaler with a dark orange mouthpiece and a peach cap placed on a surface, demonstrating proper handling for respiratory aerosol use.*

FDA Label Image

Figure F (Fluticasonepropionatehfa Spl Graphic 10)

An instructional illustration showing a side profile of a person's face exhaling, accompanied by the text advising to "Breathe out as much air as you can." This diagram suggests guidance on using an inhalation device, likely related to respiratory medication administration.*

FDA Label Image

Figure G (Fluticasonepropionatehfa Spl Graphic 11)

An instructional illustration showing a person using a metered-dose inhaler. The image depicts the correct technique with a directional arrow indicating to push down on the inhaler and breathe in the medication through the mouth.*

FDA Label Image

Figure H (Fluticasonepropionatehfa Spl Graphic 12)

An instructional illustration showing a person rinsing their mouth over a sink, with a glass of water nearby. This image likely demonstrates a step related to using an inhalation product, emphasizing mouth rinsing after use.*

FDA Label Image

Figure I (Fluticasonepropionatehfa Spl Graphic 13)

An instructional illustration showing the correct and incorrect ways to administer a metered-dose inhaler spray. The top image, labeled 'Not blocked,' depicts a clear aerosol spray from the inhaler. The bottom image, labeled 'Blocked,' shows the spray being obstructed by placing the inhaler too close to the mouthpiece or lip area.*

FDA Label Image

Figure J (Fluticasonepropionatehfa Spl Graphic 14)

An instructional diagram showing a hand using a pointed object to press or manipulate a small button or opening on the underside of a device, likely demonstrating how to remove or adjust a component on an aerosol inhaler device.*

FDA Label Image

Label Image (Lbl500906055)

Fluticasone Propionate HFA 220 mcg/1 inhalation aerosol metered spray by A-S Medication Solutions. The label displays dosage strength, storage instructions (room temperature 68-77°F, away from heat and mouthpiece down), and package quantity of 120 metered actuations. Includes NDC 50090-6055 and product number 2838-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.